Metacrine Company
Developing differentiated therapies that can improve the health of patients with liver and gastrointestinal (GI) diseases
Employee Number:
11-50
Investors Number:
14
Funding Status:
IPO
Headquarters:
San Diego, California, United States
Last Funding Date:
2019
Technology:
Immunotherapy
Estimated Revenue:
$10M to $50M
Founded Date:
2015
Last Funding Type:
Debt Financing
Investor Type:
IPO
Total Funding:
173000000
Industry:
Biotechnology, Health Care, Medical, Pharmaceutical